Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Interest Income | 116,179 | 105,915 | 94,774 | 95,056 | 92,066 |
| Interest Expense | 57,223 | 49,100 | 41,686 | 41,242 | 39,248 |
| Interest Income (Net of Interest Expense) | 58,956 | 56,815 | 53,088 | 53,814 | 52,818 |
| Non-Interest Income | 12,917 | 16,219 | 13,306 | 15,405 | 14,639 |
| Sales | 71,873 | 73,034 | 66,394 | 69,219 | 67,457 |
| Credit Losses Provision | 4,650 | 4,650 | 3,400 | 3,400 | 3,750 |
| Non Interest Expenses | 44,240 | 46,433 | 42,599 | 41,602 | 39,647 |
| Pre-tax Income | 22,983 | 21,951 | 20,395 | 24,217 | 24,060 |
| Income Tax | 7,567 | 6,521 | 6,505 | 8,209 | 8,169 |
| Other Income | 80,206 | 71,051 | 62,081 | 65,459 | 63,308 |
| Net Income | $15,416 | $15,430 | $13,890 | $16,008 | $15,891 |
| EPS Basic Continuous Ops | 29.02 | 29.17 | 26.37 | 30.44 | 30.32 |
| EPS Basic Total Ops | 28.95 | 29.61 | 26.32 | 30.26 | 30.26 |
| EPS Diluted Continuous Ops | 28.77 | 28.96 | 26.04 | 30.07 | 29.89 |
| EPS Diluted Total Ops | 28.95 | 28.95 | 26.32 | 30.26 | 29.61 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |